• FDA Extends Relizorb’s Approval to Children with Cystic Fibrosis Who Are Fed with a Tube
  • Boomer Esiason Foundation Taking Its Bike to Breathe CF Awareness Effort to Europe
  • Digestive Care’s Enzyme Replacement Therapy via G-tube Approved by FDA for CF Patients
  • Data From Vertex’s Triple-Combination Trials Show Promising Benefits for CF Patients
  • Free Online Lecture, Sponsored by GeneFo, to Focus on Intimacy and Sexuality
  • Kate Marshall, 18, Expresses Concerns Over Healthcare Bill
  • FDA Uses Kalydeco and Keytruda as Examples of How It Is Promoting Precision Medicine
  • SNSP113 Gives Antibiotics More Punch Against Bacteria Often Seen in Cystic Fibrosis, Study Find
  • Coast-to-Coast Bike Ride, Inspired by Boy with CF, Raising Money for Claire’s Place Foundation
  • Cystic Fibrosis Foundation Opens Door to Anthera Speeding Up Trial of Digestive Disorder Therapy
  • Phase 3 Study of Sollpura, Enzyme Replacement Therapy for CF Patients with EPI, Recruiting in Europe and US
  • How Certain Bacteria Resist Antibiotics to Become Virulent in CF and Other Diseases Focus of Thesis